Search results
Results from the WOW.Com Content Network
Sveriges riksdag added TMA-2 to schedule I ("substances, plant materials and fungi which normally do not have medical use") as narcotics in Sweden as of Dec 30, 1999, published by Medical Products Agency in their regulation LVFS 2004:3 listed as 2,4,5-trimetoxiamfetamin (TMA-2).
Tebbe's reagent, which is used for the methylenation of esters and ketones, is prepared from TMA and titanocene dichloride. [9] In combination with 20 to 100 mol % Cp 2 ZrCl 2 (zirconocene dichloride), the (CH 3) 2 Al-CH 3 adds "across" alkynes to give vinyl aluminium species that are useful in organic synthesis in a reaction known as ...
TMA-2 may be: TMA-2 mine; Soyuz TMA-2, a Russian space exploration mission; 2,4,5-trimethoxyamphetamine, a hallucinogenic drug;
[2] The synthesis of Al 2 O 3 from trimethylaluminum (TMA) and water is one of the best known thermal ALD examples. During the TMA exposure, TMA dissociatively chemisorbs on the substrate surface and any remaining TMA is pumped out of the chamber. The dissociative chemisorption of TMA leaves a surface covered with AlCH 3.
Shulgin explains in his book that DMMDA has 6 isomers similar to TMA. [1] DMMDA-2 is the only other isomer that has been synthesized as of yet. DMMDA-3 could be made from exalatacin (1-allyl-2,6-dimethoxy-3,4-methylenedioxybenzene). Exalatacin can be found in the essential oil of both Crowea exalata and Crowea angustifolia var. angustifolia. [2]
The mechanism that produces the hallucinogenic and entheogenic effects of 2C-TFM is most likely to result from action as a 5-HT 2A serotonin receptor agonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines. 2C-TFM displaced radiolabelled ketanserin from 5-HT 2A/C receptors with a K i of 74.5 nM, as compared to a K i of 80.9 nM for the ...
A U.K. woman had her breast cancer detected through AI after a routine mammogram came back as normal. Experts Drs. Nicole Saphier and Harvey Castro discuss the power of AI in cancer care.
2,5-Dimethoxy-4-iodoamphetamine (DOI) is a psychedelic drug and a substituted amphetamine. Unlike many other substituted amphetamines, however, it is not primarily a stimulant . [ 3 ] DOI has a stereocenter and R -(−)-DOI is the more active stereoisomer .